Phase IIa laquinimod trial results show positive data for potential use in active Crohn's disease Active Biotech, 22 Oct 2012 Accessed on 1 Nov 2012 from http://www.activebiotech.com/press-releases-1?pressurl=http://cws.huginonline.com/A/1002/PR/201210/1651043.xml. CommentRecommendBookmarkWatch